PetMed Express, Inc. (NASDAQ:PETS) Stock Holdings Boosted by Squarepoint Ops LLC

Squarepoint Ops LLC increased its position in PetMed Express, Inc. (NASDAQ:PETS) by 41.4% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 17,686 shares of the company’s stock after acquiring an additional 5,180 shares during the period. Squarepoint Ops LLC owned approximately 0.09% of PetMed Express worth $85,000 at the end of the most recent reporting period.

Several other hedge funds have also recently bought and sold shares of the company. Quarry LP bought a new stake in PetMed Express during the fourth quarter worth approximately $47,000. Virtu Financial LLC acquired a new position in shares of PetMed Express during the 4th quarter valued at $58,000. Boothbay Fund Management LLC bought a new stake in shares of PetMed Express in the 4th quarter worth $59,000. Diametric Capital LP bought a new stake in shares of PetMed Express in the 4th quarter worth $86,000. Finally, Blair William & Co. IL lifted its holdings in shares of PetMed Express by 95.2% in the fourth quarter. Blair William & Co. IL now owns 20,300 shares of the company’s stock valued at $98,000 after buying an additional 9,900 shares during the period. 73.33% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

A number of equities analysts recently issued reports on PETS shares. Morgan Stanley decreased their target price on PetMed Express from $3.50 to $3.20 and set an “underweight” rating on the stock in a report on Thursday, April 17th. Wall Street Zen lowered PetMed Express from a “buy” rating to a “hold” rating in a research report on Wednesday, May 7th.

PetMed Express Stock Up 4.0%

Shares of NASDAQ:PETS opened at $4.12 on Tuesday. The company has a market cap of $85.10 million, a price-to-earnings ratio of 412.41 and a beta of 0.81. The business has a 50 day moving average price of $3.54 and a 200 day moving average price of $4.32. PetMed Express, Inc. has a twelve month low of $2.90 and a twelve month high of $6.85.

Insider Activity at PetMed Express

In related news, major shareholder Silvercape Investments Ltd acquired 7,401 shares of the company’s stock in a transaction dated Tuesday, May 20th. The stock was purchased at an average price of $3.95 per share, with a total value of $29,233.95. Following the completion of the purchase, the insider now owns 2,307,719 shares in the company, valued at $9,115,490.05. This trade represents a 0.32% increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Sandra Yvette Campos sold 60,463 shares of the stock in a transaction dated Wednesday, April 30th. The stock was sold at an average price of $3.31, for a total transaction of $200,132.53. Following the sale, the chief executive officer now owns 578,524 shares of the company’s stock, valued at approximately $1,914,914.44. This represents a 9.46% decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.10% of the stock is currently owned by corporate insiders.

PetMed Express Profile

PetMed Express, Inc, together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and household pet supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes.